ResMed RMD Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net revenue by Business | |||||
| Residential Care Software | $641.44M+9.8% | $584.13M+17.3% | $497.98M— | —— | |
| Sleep and Breathing Health | $4.5B+9.8% | $4.1B+10.1% | $3.73B— | —— | |
| Operating Income (Loss) by Business | |||||
| Residential Care Software | $205M+32.7% | $154.45M+33.5% | $115.66M— | —— | |
| Sleep And Breathing Health | $1.96B+16.8% | $1.68B+16.2% | $1.45B— | —— | |
| Selling, general, and administrative by Business | |||||
| Residential Care Software | $143.52M-0.3% | $144M+19.5% | $120.48M— | —— | |
| Sleep And Breathing Health | $491.59M+8.9% | $451.33M+1.8% | $443.47M— | —— | |
| Cost of Sales by Business | |||||
| Residential Care Software | $194.96M+2.5% | $190.19M+8.9% | $174.72M— | —— | |
| Sleep And Breathing Health | $1.85B+4.0% | $1.78B+7.4% | $1.66B— | —— | |
| Business acquisitions by Business | |||||
| Residential Care Software | $0— | —— | —— | —— | |
| Sleep And Breathing Health | $101.32M— | —— | —— | —— | |
| Depreciation and amortization by segment by Business | |||||
| Residential Care Software | $9.47M-7.6% | $10.24M+12.3% | $9.12M— | —— | |
| Sleep And Breathing Health | $110.54M+28.4% | $86.07M+4.3% | $82.54M— | —— | |
| R&D by Business | |||||
| Residential Care Software | $97.96M+2.6% | $95.49M+9.6% | $87.12M— | —— | |
| Sleep And Breathing Health | $196.34M+5.3% | $186.46M+6.3% | $175.39M— | —— | |
| Goodwill (note 4) by Business | |||||
| Residential Care Software | $8.43B— | —— | —— | —— | |
| Sleep And Breathing Health | $3.16B— | —— | —— | —— | |
| Goodwill, Foreign Currency Translation, Gain (Loss) by Business | |||||
| Residential Care Software | $78.58M— | —— | —— | —— | |
| Sleep And Breathing Health | $24.91M— | —— | —— | —— | |
| Adjustment to fair values of preliminary purchase price allocations by Business | |||||
| Residential Care Software | $0— | —— | —— | —— | |
| Net revenue by segment by Product | |||||
| Residential Care Software | $641.44M+9.8% | $584.13M+17.3% | $497.98M— | —— | |
| Sleep And Breathing Health | $4.5B+9.8% | $4.1B+10.1% | $3.73B— | —— | |
| Cost of sales (exclusive of amortization shown separately below) by Product | |||||
| Residential Care Software | $194.96M+2.5% | $190.19M+9.3% | $173.98M— | —— | |
| Sleep And Breathing Health | $1.86B+3.2% | $1.81B+8.7% | $1.66B— | —— | |
| Amortization of Intangible Assets by Product | |||||
| Residential Care Software | $25.47M-7.2% | $27.45M+9.6% | $25.06M— | —— | |
| Sleep And Breathing Health | $6.65M+20.5% | $5.52M+3.3% | $5.34M— | —— | |
| Net revenue by segment by Geography | |||||
| Combined Europe, Asia and other markets | $1.51B+9.3% | $1.38B+11.0% | $1.24B+3.9% | $1.2B+6.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ResMed break its business down?
- ResMed (RMD) reports net revenue by business across 2 parts — Residential Care Software and Sleep and Breathing Health. Each is extracted from the segment footnotes and tracked over time.
- Where does ResMed's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ResMed's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
